Immucell (ICCC) EV to EBITDA (2010 - 2026)
Immucell's EV to EBITDA was 11.61 in Q3 2026, up 14.0% from 10.19 a year earlier but down 10.8% from the prior quarter.
Immucell (ICCC) EV to EBITDA (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Immucell's EV to EBITDA was 8.82 through Sep 30, 2026, up 19.1% year-over-year; for FY2025, it came in at 11.50, down 68.8% from FY2024.
- In earlier years, EV to EBITDA was 36.90 in FY2024, 185.89 in FY2022 (+889.0%) and 18.80 in FY2021 (-41.5%).
- Quarterly EV to EBITDA has moved between 9.72 (Q1 2026) and 2031.46 (Q1 2024) over five years.
- Compared with a year earlier, EV to EBITDA was higher in two of the last six quarters, with an average decline of 44.4%.
- The best year-over-year quarter for EV to EBITDA over five years was Q4 2022 (growth of 886.2%); the worst was Q1 2025 (a decline of 99.3%).
- Per Business Quant data, ICCC's EV to EBITDA in the three quarters before Q3 2026 was 13.01 (Q2 2026), 9.72 (Q1 2026) and 11.50 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn |
| 10 | Immucell | 102.43 Mn | 75.03 Mn | 3.56 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 11.61 |
| Jun 30, 2026 | 13.01 |
| Mar 31, 2026 | 9.72 |
| Dec 31, 2025 | 11.50 |
| Sep 30, 2025 | 10.19 |
| Jun 30, 2025 | 12.57 |
| Mar 31, 2025 | 14.90 |
| Dec 31, 2024 | 36.90 |
| Sep 30, 2024 | 53.35 |
| Mar 31, 2024 | 2,031.46 |
| Dec 31, 2022 | 185.89 |
| Sep 30, 2022 | 24.59 |
| Jun 30, 2022 | 19.61 |
| Mar 31, 2022 | 17.02 |
| Dec 31, 2021 | 18.85 |
| Sep 30, 2021 | 31.43 |
| Jun 30, 2021 | 44.12 |
| Mar 31, 2021 | 136.01 |
| Dec 31, 2020 | 36.20 |
| Sep 30, 2020 | 25.44 |
Immucell EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ICCC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();